Alvotech Kicks Off Trials For Eylea Biosimilar

AVT06 Proposed Version Of Aflibercept Enters Clinical Studies

 
• By David Wallace
  
Eye data binary
Trials are beginning for Alvotech’s aflibercept biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products